Clinical Trial 46169

Worcester, MA 01605


Summary:

RSVP Study: A Clinical Study Evaluating a Mechanism of Action for Stable Vitiligo

Vitiligo is a disease affecting approximately 6.5 million people in the U.S. resulting in loss of color, or pigmentation, in patches of skin that impacts the quality of life for those living with the condition.

Clinical studies are underway exploring the use of RECELL for the repigmentation of stable vitiligo.

Why is the RSVP Study being done?

The RSVP Study is evaluating the application of Spray-On SkinTM Cells, prepared using the investigational RECELL Device, for safe and effective repigmentation of stable vitiligo.

Is the RSVP Study an option for you?

You may be able to participate in the RSVP Study if all of the following criteria are met:

  • You are 18 years of age or older.
  • You have stable vitiligo (not changing in size).
  • You can provide photos of your vitiligo that were taken within the past 12 months (photographs can be from you or from your doctor).

There are other eligibility requirements that the study doctor will review with you.


Available At:

If you want more information about the RSVP Study and whether it is an option for you, please CLICK HERE or talk to your doctor.

Click here for a list of study sites.

 


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.